Bernard C, Rooker J, Morey T, Long R, Sweeney K, Powers B
Kans J Med. 2025; 17(5):113-118.
PMID: 39758547
PMC: 11698232.
DOI: 10.17161/kjm.vol17.21831.
Dania V, Stavropoulos N, Gavriil P, Trikoupis I, Koulouvaris P, Savvidou O
Medicina (Kaunas). 2024; 60(10).
PMID: 39459462
PMC: 11509811.
DOI: 10.3390/medicina60101675.
Gelderblom H, Razak A, Taylor M, Bauer T, Wilky B, Martin-Broto J
Clin Cancer Res. 2024; 30(18):3996-4004.
PMID: 38995311
PMC: 11393540.
DOI: 10.1158/1078-0432.CCR-24-0103.
Huang W, Gao G, Yang Q, Chen Z, Qiu Y, Gao J
World J Clin Cases. 2022; 10(29):10763-10771.
PMID: 36312472
PMC: 9602230.
DOI: 10.12998/wjcc.v10.i29.10763.
Bernthal N, Healey J, Palmerini E, Bauer S, Schreuder H, Leithner A
J Surg Oncol. 2022; 126(8):1520-1532.
PMID: 36006054
DOI: 10.1002/jso.27067.
Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.
Robert M, Farese H, Miossec P
Front Immunol. 2022; 13:820046.
PMID: 35265077
PMC: 8899011.
DOI: 10.3389/fimmu.2022.820046.
Imatinib, a New Adjuvant Medical Treatment for Multifocal Villonodular Synovitis Associated to Noonan Syndrome: A Case Report and Literature Review.
Dalla-Torre R, Crenn V, Menu P, Isidor B, Guillot P, Le Goff B
Front Med (Lausanne). 2022; 8:817873.
PMID: 35111788
PMC: 8802824.
DOI: 10.3389/fmed.2021.817873.
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Peterfy C, Chen Y, Countryman P, Chmielowski B, Anthony S, Healey J
Future Oncol. 2022; 18(12):1449-1459.
PMID: 35040698
PMC: 11197039.
DOI: 10.2217/fon-2021-1437.
A New Simple and Practical Clinical Classification for Tenosynovial Giant Cell Tumors of the Knee.
Zheng K, Yu X, Hu Y, Xu M, Zhang J
Orthop Surg. 2021; 14(2):290-297.
PMID: 34914180
PMC: 8867407.
DOI: 10.1111/os.13179.
Molecular targeted therapy for advanced or metastatic soft tissue sarcoma.
Yuan J, Li X, Yu S
Cancer Control. 2021; 28:10732748211038424.
PMID: 34844463
PMC: 8727831.
DOI: 10.1177/10732748211038424.
Tenosynovial giant cell tumor involving the cervical spine: A case report.
Zhu J, Li M, Liang Y, Wu J
World J Clin Cases. 2021; 9(14):3394-3402.
PMID: 34002150
PMC: 8107909.
DOI: 10.12998/wjcc.v9.i14.3394.
Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.
Sparber-Sauer M, Orbach D, Navid F, Hettmer S, Skapek S, Corradini N
Br J Cancer. 2021; 124(10):1637-1646.
PMID: 33723397
PMC: 8110972.
DOI: 10.1038/s41416-021-01320-1.
Targeting Tumor-Associated Macrophages in the Pediatric Sarcoma Tumor Microenvironment.
Koo J, Hayashi M, Verneris M, Lee-Sherick A
Front Oncol. 2020; 10:581107.
PMID: 33381449
PMC: 7769312.
DOI: 10.3389/fonc.2020.581107.
Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT).
Brahmi M, Cassier P, Dufresne A, Chabaud S, Karanian M, Meurgey A
PLoS One. 2020; 15(5):e0233046.
PMID: 32433669
PMC: 7239463.
DOI: 10.1371/journal.pone.0233046.
Multiple systemic treatment options in a patient with malignant tenosynovial giant cell tumour.
Rebuzzi S, Grassi M, Catalano F, Buscaglia M, Bertulli R, Satragno C
Anticancer Drugs. 2019; 31(1):80-84.
PMID: 31567307
PMC: 6903349.
DOI: 10.1097/CAD.0000000000000844.
Tenosynovial giant cell tumor of the cervical spine: a case report.
Furuhata R, Iwanami A, Tsuji O, Nagoshi N, Suzuki S, Okada E
Spinal Cord Ser Cases. 2019; 5:23.
PMID: 31240119
PMC: 6461752.
DOI: 10.1038/s41394-019-0172-1.
Effect of chemotherapy on cancer stem cells and tumor-associated macrophages in a prospective study of preoperative chemotherapy in soft tissue sarcoma.
Skubitz K, Wilson J, Cheng E, Lindgren B, Boylan K, Skubitz A
J Transl Med. 2019; 17(1):130.
PMID: 30999901
PMC: 6471853.
DOI: 10.1186/s12967-019-1883-6.
First-Line Therapy for Metastatic Soft Tissue Sarcoma.
Meyer M, Seetharam M
Curr Treat Options Oncol. 2019; 20(1):6.
PMID: 30675651
DOI: 10.1007/s11864-019-0606-9.
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
Nakayama R, Jagannathan J, Ramaiya N, Ferrone M, Raut C, Ready J
BMC Cancer. 2018; 18(1):1296.
PMID: 30594158
PMC: 6311045.
DOI: 10.1186/s12885-018-5188-6.
Pigmented villonodular synovitis of the cervical spine: case report and review of the literature.
Koontz N, Quigley E, Witt B, Sanders R, Shah L
BJR Case Rep. 2018; 2(1):20150264.
PMID: 30364455
PMC: 6195912.
DOI: 10.1259/bjrcr.20150264.
